Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older

This study has been completed.

Sponsor:

Collaborator:

Wyeth is now a wholly owned subsidiary of Pfizer

Information provided by:

MedImmune LLC

ClinicalTrials.gov Identifier:

NCT00192153

First received: September 12, 2005

Last updated: October 23, 2006

Last verified: October 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2001
Estimated Primary Completion Date:	No date given